Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle

BackgroundAn important aspect of inclusion-body myositis (IBM) vacuolated muscle fibers (VMF) is abnormal accumulation of amyloid-&bgr; precursor protein (A&bgr;PP) epitopes and its product, amyloid-&bgr; (A&bgr;), and of phosphorylated tau (p-tau) in the form of paired helical filaments. Lipoprotein receptors and cholesterol are known to play an important role in A&bgr;PP processing, A&bgr; production, and tau phosphorylation. MethodsIn 10 IBM and 22 control muscle biopsies the authors immunolocalized low-density lipoprotein receptor (LDLR), very low-density lipoprotein receptor (VLDLR), and low-density lipoprotein receptor-related protein (LRP), and colocalized them with A&bgr;, p-tau, APOE, and free cholesterol. ResultsIn each biopsy, virtually all IBM VMF had strong LDLR-immunoreactive inclusions, which colocalized with A&bgr;, APOE, p-tau, and free cholesterol. VLDLR was increased mainly diffusely, but in approximately 50% of the VMF it was also accumulated in the form of inclusions colocalizing with A&bgr;, APOE, and free cholesterol, but not with p-tau. LRP inclusions were present in a few VMF. In all myopathies, a subset of regenerating and necrotizing muscle fibers had prominent diffuse accumulation of both LDLR and free cholesterol. At normal neuromuscular junctions (NMJ) postsynaptically, LDLR and VLDLR, but not LRP, were immunoreactive. Conclusions1) Abnormal accumulation of LDLR, VLDLR, LRP, and cholesterol within IBM vacuolated muscle fibers suggests novel roles for them in the IBM pathogenesis. 2) Expression of LDLR and VLDLR at normal NMJ suggests physiologic roles for them in transsynaptic signaling pathways, increased internalization of lipoproteins there, or both. 3) Increased LDLR and free cholesterol in some regenerating and necrotizing muscle fibers suggest a role for them in human muscle fiber growth and repair and necrotic death.

[1]  W. Engel,et al.  Difference in Expression of Phosphorylated Tau Epitopes between Sporadic Inclusion‐body Myositis and Hereditary Inclusion‐body Myopathies , 1996, Journal of neuropathology and experimental neurology.

[2]  T. Farag.  Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.

[3]  D J Stephens,et al.  The role of cholesterol in the biosynthesis of beta-amyloid. , 1999, Neuroreport.

[4]  W. Engel.  Muscle biopsies in neuromuscular diseases. , 1967, Pediatric clinics of North America.

[5]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Y. Ihara,et al.  Accumulation and Aggregation of Amyloid β-Protein in Late Endosomes of Niemann-Pick Type C Cells* , 2001, The Journal of Biological Chemistry.

[7]  B. Hyman,et al.  Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. , 2000, The Journal of biological chemistry.

[8]  D. Strickland,et al.  Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. , 1990, The Journal of biological chemistry.

[9]  W. Engel,et al.  beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. , 1993, Annals of neurology.

[10]  D. Strickland,et al.  The mammalian low-density lipoprotein receptor family. , 1999, Annual review of nutrition.

[11]  E. Corder,et al.  Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer’s disease , 1999, Cellular and Molecular Life Sciences CMLS.

[12]  W. Klein,et al.  Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. , 1996, The Journal of biological chemistry.

[13]  M. Brown,et al.  Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. , 1981, The Journal of biological chemistry.

[14]  W. Engel,et al.  β‐Amyloid precursor epitopes in muscle fibers of inclusion body myositis , 1993 .

[15]  W. Markesbery.  The role of oxidative stress in Alzheimer disease. , 1999, Archives of neurology.

[16]  A. Roses,et al.  Apolipoprotein E alleles in sporadic inclusion‐body myositis and hereditary inclusion‐body myopathy , 1996, Annals of neurology.

[17]  P. Bugelski,et al.  A Novel Technique For Mapping the Lipid Composition of Atherosclerotic Fatty Streaks by En Face Fluorescence Microscopy , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  J. Herz.  The LDL Receptor Gene Family (Un)Expected Signal Transducers in the Brain , 2001, Neuron.

[19]  B. Ghetti,et al.  Neurofibrillary tangles in Niemann-Pick disease type C , 2004, Acta Neuropathologica.

[20]  H. Kruth,et al.  Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin-positive, oil-red-O-negative particles. , 1984, The American journal of pathology.

[21]  R. Zechner,et al.  Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: triglyceride droplets are surrounded by cholesterol-rich ER-like surface layer structures. , 2000, Journal of cell science.

[22]  U. Igbavboa,et al.  Lipid Binding to Amyloid β‐Peptide Aggregates: Preferential Binding of Cholesterol as Compared with Phosphatidylcholine and Fatty Acids , 1997, Journal of neurochemistry.

[23]  K. Weisgraber,et al.  Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. , 1991, Journal of Biological Chemistry.

[24]  H. Börnig,et al.  Staining of cholesterol with the fluorescent antibiotic "filipin". , 1974, Acta histochemica.

[25]  M. Bronner,et al.  Localization and regulation of the human very low density lipoprotein/apolipoprotein-E receptor: trophoblast expression predicts a role for the receptor in placental lipid transport. , 1995, Endocrinology.

[26]  Q. Fan,et al.  Cholesterol‐dependent modulation of tau phosphorylation in cultured neurons , 2001, Journal of neurochemistry.

[27]  R. Parton,et al.  Endocytosis in skeletal muscle fibers. , 1999, Experimental cell research.

[28]  J. Richardson,et al.  Interactions of the Low Density Lipoprotein Receptor Gene Family with Cytosolic Adaptor and Scaffold Proteins Suggest Diverse Biological Functions in Cellular Communication and Signal Transduction* , 2000, The Journal of Biological Chemistry.

[29]  W. Klein,et al.  Cholesterol Modulates -Secretase Cleavage of Amyloid Precursor Protein (*) , 1996, The Journal of Biological Chemistry.

[30]  E. Giniger,et al.  Alzheimer's Disease Neurodevelopment Converges with Neurodegeneration , 2000, Cell.

[31]  P. Lansbury,et al.  A detergent-insoluble membrane compartment contains A beta in vivo. , 1998, Nature medicine.

[32]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Rosenberg.  The molecular and genetic basis of AD: The end of the beginning , 2000, Neurology.

[34]  A. Saunders.  Apolipoprotein E and Alzheimer Disease: An Update on Genetic and Functional Analyses , 2000, Journal of neuropathology and experimental neurology.

[35]  W. Engel,et al.  Cyclin-dependent kinase 5 colocalizes with phosphorylated tau in human inclusion-body myositis paired-helical filaments and may play a role in tau phosphorylation , 2000, Neuroscience Letters.

[36]  E. Mandelkow,et al.  Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Haass,et al.  Cholesterol-dependent Generation of a Seeding Amyloid β-Protein in Cell Culture* , 1999, The Journal of Biological Chemistry.

[38]  A. Norman,et al.  Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of filipin with cholesterol. , 1972, The Journal of biological chemistry.

[39]  E. Ikonen,et al.  How cells handle cholesterol. , 2000, Science.

[40]  W. Engel,et al.  Inclusion‐Body Myositis: Newest Concepts of Pathogenesis and Relation to Aging and Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[41]  K. Weisgraber,et al.  Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies , 1996, Annals of neurology.